+ Filter
Loading...
Custom Services order now ship next day

Cixutumumab

Anti-Cixutumumab Recombinant Antibody Products

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

More Infomation

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

For Research Use Only. Not For Clinical Use.


Cixutumumab has been evaluated in clinical trials for treating lung cancer, malignant neoplasms, leukemia, mast-cell neoplasms, non-small-cell lung carcinoma, and adenocarcinoma of the prostate, known for its high affinity for the insulin-like growth factor-I receptor (IGF-IR) overexpressed in various tumors.
  • 0
  • 0
Cart
    Go to compare

    Go to compare